Increase Your Impact Factor: Study Registration on the HEAL Data Platform

In July 2022, Dr. Rebecca Baker, Director of the NIH HEAL Initiative^®, announced the official launch of the HEAL Data Platform, a secure, cloud-based platform through which users will be able to access data from hundreds of HEAL-funded studies on the prevention and treatment of pain, opioid use disorder, and related conditions. By providing standardized access to data from across the NIH HEAL Initiative together with powerful search and analytical tools, the HEAL Data Platform will catalyze scientific discovery and innovation, leading to improved treatments and outcomes for those affected by pain and opioid use disorder. 

In this webinar, the HEAL Data Platform Team will lead a presentation on how HEAL investigators can register their study on the Platform and provide metadata describing their study. Doing so is the first step in preparing to share your data and complying with the HEAL Public Access and Data Sharing policy. Following this presentation, the HEAL Data Platform Team will lead a panel discussion and Q&A.

Phil Schumm is a statistician and Director of the Research Computing Group in the Department of Public Health Sciences at the University of Chicago. He has served as technical director for numerous Data Coordinating Centers, including the Inflammatory Bowel Disease Genetics Consortium funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the International IBD Genetics Consortium for which he has led development of a Data Commons. He is Co-PI (with Robert Grossman) of the HEAL Data Platform and co-leads the Data and Analytic Support Core for the Justice Community Opioid Innovation Network, funded by the National Institute on Drug Abuse.

Eric Giger received his B.A. in Economics from the University of Chicago. He's been with the Center for Translational Data Science at the University of Chicago since the beginning of this year. Having previously worked on the data collection end of clinical addiction research, Mr. Giger now provides User Support to researchers on the HEAL Data Platform, eager to help those helping to end addiction long-term.

Brady Granier earned his bachelor of science degree in nursing in 1995. During his nursing career, he specialized in the critical care areas of ER/ICU/CCU and CICU. He also moonlighted as a home health nurse, critical care air transport nurse, and TV studio set medic. In 1996, he moved to California as a travel nurse and spent most of his remaining years in healthcare as the charge nurse in the emergency room at White Memorial Hospital in downtown Los Angeles. After leaving nursing and during the 12 years prior to joining BioCorRx® in 2013, Mr. Granier was involved in sales management, media sales, and business development. A few years after returning to healthcare, he co-founded BioCorRx Pharmaceuticals, Inc., after seeing the need to develop more medications to treat addiction such as BICX104, an implantable naltrexone pellet for alcohol use disorder and opioid use disorder, currently in human trials.

Allie Gartland-Gray, M.P.S., is a research data analyst in the Research Computing Division at RTI International. She has experience in data collection, management, and storage, and has nearly 4 years of experience working in the field of health informatics in a combination of both academic and professional settings. Ms. Gartland-Gray’s educational background is in biology and biomedical health and informatics, and she leverages this knowledge as a HEAL Steward to help develop tools and guidance for research data governance, curation, and deposition.

Marisa Briones, Ph.D., is the CEO/Co-founder of BDH Pharma in Los Angeles, California. Dr. Briones earned her Ph.D. in molecular and medical pharmacology from the University of California, Los Angeles, where her graduate work focused on pharmacokinetics, drug-drug interactions, and mechanisms of drug action. She has more than 10 years of extensive research experience ranging from basic, pre-clinical research, translational science, clinical research, and clinical trials.

Georgene Hergenroeder, Ph.D., serves as Associate Professor in the Vivian L. Smith Department of Neurosurgery at the University of Texas Health Science Center at Houston. Dr. Hergenroeder’s primary research interests center on improving patient outcomes after spinal cord and brain injury. Her research focus has been on biomarker discovery in order to predict which patients may benefit from future intervention.
 

For More Information, Contact:

Julie Hayes at [email protected]